Repros Therapeutics Inc  

(Public, NASDAQ:RPRX)   Watch this stock  
Find more results for RPRX
6.50
+0.28 (4.50%)
Oct 24 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 6.14 - 6.55
52 week 5.91 - 22.57
Open 6.18
Vol / Avg. 708,829.00/1.69M
Mkt cap 143.74M
P/E     -
Div/yield     -
EPS -1.32
Shares 23.11M
Beta 0.93
Inst. own 91%
Nov 10, 2014
Q3 2014 Repros Therapeutics Inc Earnings Release - 9:30AM EST - Add to calendar
Sep 26, 2014
Repros Therapeutics Inc at BioCentury Publications NewsMakers in the Biotech Industry
Aug 11, 2014
Q2 2014 Repros Therapeutics, Inc. Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -51.31% -52.40%
Return on average equity -54.51% -56.31%
Employees 28 -
CDP Score - -

Address

SUITE B-7, 2408 Timberloch Place
THE WOODLANDS, TX 77380
United States - Map
+1-281-7193400 (Phone)
+1-281-7193446 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Repros Therapeutics, Inc. is a United States-based company that develops products and services for the management of reproductive health. The Company's products include: contraceptives, vaccines for prostate cancer, enhanced topical treatment for genital herpes as well as treatments for male and female sexual dysfunction. It focuses on the development of oral small molecule drugs to address major unmet medical needs in male and female health.

Officers and directors

Nola E. Masterson Independent Chairman of the Board
Age: 67
Bio & Compensation  - Reuters
Joseph S. Podolski President, Chief Executive Officer, Director
Age: 66
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Katherine A. Anderson CPA Chief Financial Officer, Chief Accounting Officer, Secretary
Age: 56
Bio & Compensation  - Reuters
Jaye L. Thompson Ph.D. Senior Vice President - Clinical and Regulatory
Age: 48
Bio & Compensation  - Reuters
Ronald D. Wiehle Ph.D. Vice President - Research & Development
Age: 65
Bio & Compensation  - Reuters
Joachim F. Wernicke Chief Medical Officer
Age: 66
Bio & Compensation  - Reuters
Michael Suesserman Director
Age: 49
Bio & Compensation  - Reuters
Daniel F. Cain Independent Director
Age: 68
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Saira Ramasastry Independent Director
Age: 38
Bio & Compensation  - Reuters
Michael G. Wyllie Ph.D. Independent Director
Age: 63
Bio & Compensation  - Reuters